1. Home
  2. FSBW vs LCTX Comparison

FSBW vs LCTX Comparison

Compare FSBW & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$43.99

Market Cap

326.3M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
LCTX
Founded
1936
1990
Country
United States
United States
Employees
537
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
326.3M
301.7M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
FSBW
LCTX
Price
$43.99
$1.07
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$46.00
$6.25
AVG Volume (30 Days)
18.1K
932.4K
Earning Date
04-21-2026
05-14-2026
Dividend Yield
2.79%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$4,612,000.00
$14,556,000.00
Revenue This Year
$14.94
$109.40
Revenue Next Year
$10.47
N/A
P/E Ratio
$21.15
N/A
Revenue Growth
44.80
53.24
52 Week Low
$36.85
$1.00
52 Week High
$45.85
$2.09

Technical Indicators

Market Signals
Indicator
FSBW
LCTX
Relative Strength Index (RSI) 53.07 39.65
Support Level $40.96 $1.00
Resistance Level $43.70 $1.18
Average True Range (ATR) 0.95 0.06
MACD -0.01 0.00
Stochastic Oscillator 70.87 36.11

Price Performance

Historical Comparison
FSBW
LCTX

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: